AMD3465, a Novel CXCR4 Receptor Antagonist, Abrogates Schistosomal Antigen-Elicited (Type-2) Pulmonary Granuloma Formation

Abstract
No abstract available
Funding Information
  • U.S. Department of Veterans Affairs (A143460, NO1-AI-55270)
  • National Institute of Allergy and Infectious Diseases (A143460, NO1-AI-55270)
  • National Institutes of Health (A143460, NO1-AI-55270)